Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)
Hainsworth, John D., Becker, Kevin P., Mekhail, Tarek, Chowdhary, Sajeel A., Eakle, Janice Faulkner, Wright, David, Langdon, Robert M., Yost, Kathleen J., Padula, Gilbert Darin Anthony, West-Osterfield, Kimberly, Scarberry, Meredith, Shaifer, Candice A., Shastry, Mythili, Burris, Howard A., Shih, Kent
Published in Journal of neuro-oncology (01.09.2019)
Published in Journal of neuro-oncology (01.09.2019)
Get full text
Journal Article
Managing painful procedures in children with cancer
Hockenberry, Marilyn J, McCarthy, Kathy, Taylor, Olga, Scarberry, Meredith, Franklin, Quinn, Louis, Chrystal U, Torres, Laura
Published in Journal of pediatric hematology/oncology (01.03.2011)
Published in Journal of pediatric hematology/oncology (01.03.2011)
Get more information
Journal Article